| Ethyl 5-[(2S,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-2-methyl-3-furoate | IC50 | 12000.0 [1] |
| Ethyl 5-[(2S,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-2-methyl-3-furoate | Ki | 6400.0 [1], 6600.0 [2] |
| (1s,2s,3s,6r)-4-(Hydroxymethyl)-6-(Octylamino)cyclohex-4-Ene-1,2,3-Triol | IC50 | 125.0 [1] |
| (1s,2s,3s,6r)-4-(Hydroxymethyl)-6-(Octylamino)cyclohex-4-Ene-1,2,3-Triol | Ki | 300.0 [1], 510.0 [2] |
| (3R,4S,5R,6R)-5-(Hydroxymethyl)-6-pentylpiperidine-3,4-diol | IC50 | 8.0 [1], 10.0 [2], 180.0 [3] |
| [(1S,2R,6S,8S)-10,10-Dimethyl-3,7,9,11-tetraoxa-4-azatricyclo[6.3.0.02,6]undec-4-en-5-yl]methanol | IC50 | 150000.0 [1], 1000000.0 [2] |
| [(1S,2R,6S,8S)-10,10-Dimethyl-3,7,9,11-tetraoxa-4-azatricyclo[6.3.0.02,6]undec-4-en-5-yl]methanol | Ki | 72000.0 [1] |
| 5-[(2S,3S,4R)-3,4-Dihydroxypyrrolidin-2-yl]-N,N-diethyl-2-methyl-3-furamide | IC50 | 65000.0 [1], 1000000.0 [2] |
| 5-[(2S,3S,4R)-3,4-Dihydroxypyrrolidin-2-yl]-N,N-diethyl-2-methyl-3-furamide | Ki | 13000.0 [1] |
| D-Galacto-Isofagomine | IC50 | 240.0 [1], 12000.0 [2] |
| Methyl 6-[[(2S)-2-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]-6-[(2R,3S,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]hexanoyl]amino]hexanoate | IC50 | 7800.0 [1] |
| Methyl 6-[[(2S)-2-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]-6-[(2R,3S,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]hexanoyl]amino]hexanoate | Ki | 600.0 [1] |
| 2-(2,2-Dihydroxy-ethyl)-pyrrolidine-3,4-diol | IC50 | 110000.0 [1] |
| 2-(2,2-Dihydroxy-ethyl)-pyrrolidine-3,4-diol | Ki | 25000.0 [1] |
| N-[(3R,4R,5S)-5-(1,2-Dihydroxyethyl)-2-hydroxy-4-[[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]oxolan-3-yl]acetamide | IC50 | 9400.0 [1] |
| N-[(3R,4R,5S)-5-(1,2-Dihydroxyethyl)-2-hydroxy-4-[[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]oxolan-3-yl]acetamide | Ki | 7500.0 [1] |
| Sodium | IC50 | 100000.0 [1] |
| Migalastat | IC50 | 90000.0 [1] |
| Afegostat | IC50 | 10000.0 [1] |
| 3-Hydroxy-4-((2-hydroxynaphthyl)azo)naphthalene-1-sulphonic acid | IC50 | 600000.0 [1] |
| Jodphthalein sodium | IC50 | 200000.0 [1] |
| Rose Bengal lactone | IC50 | 80000.0 [1] |
| Piperidine-3,4,5-triol | IC50 | 40000.0 [1] |
| 4-(4-Bromophenylazo)phenol | IC50 | 90000.0 [1] |
| (3R,4S)-Pyrrolidine-3,4-diol | IC50 | 720000.0 [1] |
| N'1,N'2-Bis(2-Hydroxybenzylidene)Oxalohydrazide | IC50 | 180000.0 [1] |
| (E)-3-(4-Isopropylbenzylidene)indolin-2-one | IC50 | 55000.0 [1] |
| 4-[2-(2,4-Difluoroanilino)-4-thiazolyl]pyrocatechol | IC50 | 320000.0 [1] |
| 1-Naphthalenesulfonic acid, 3-hydroxy-4-[(1-hydroxy-2-naphthalenyl)azo]- | IC50 | 600000.0 [1] |
| (1R,7S)-1,7,8,9,10,10-Hexachloro-4-(2,4-dinitroanilino)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione | IC50 | 150000.0 [1] |
| (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-(4-phenyltriazol-1-yl)oxane-3,4,5-triol | Ki | 330000.0 [1] |
| D&C Red No. 30 | IC50 | 300000.0 [1] |
| 5-(Dimethylamino)-N-[6-[(2R,3S,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]hexyl]naphthalene-1-sulfonamide | Ki | 300.0 [1] |
| Methyl (2S)-2-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]-6-[(2R,3S,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]hexanoate | Ki | 700.0 [1] |
| 5-[(2S,3S,4R)-3,4-Dihydroxypyrrolidin-2-yl]-N-isopropyl-2-methyl-3-furamide | IC50 | 500000.0 [1] |
| (3R,4S,5R,6R)-5-(Hydroxymethyl)-6-methylpiperidine-3,4-diol | IC50 | 250.0 [1] |
| (1S,2S,3S,4R)-Cyclohex-5-ene-1,2,3,4-tetrol | IC50 | 600000.0 [1] |
| (1S,2S,3S,6R)-4-(Hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol;hydrochloride | IC50 | 1700.0 [1] |
| (3R,4S,5R,6R)-5-(Hydroxymethyl)-6-nonylpiperidine-3,4-diol | IC50 | 0.4 [1] |
| (3R,4S,5R,6R)-6-(2-Hydroxyethyl)-5-(hydroxymethyl)piperidine-3,4-diol | IC50 | 2420.0 [1] |
| N-[4-[(2R,3R,4S,5R)-4,5-Dihydroxy-3-(hydroxymethyl)piperidin-2-yl]butyl]-5-(dimethylamino)naphthalene-1-sulfonamide | IC50 | 210.0 [1] |
| 5-(Dimethylamino)-N-[6-[[(1R,2S,3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclopentyl]amino]hexyl]naphthalene-1-sulfonamide | Ki | 290.0 [1] |
| (1S,2S,3S,4R,5R)-4-(6-Aminohexylamino)-5-(hydroxymethyl)cyclopentane-1,2,3-triol | Ki | 9200.0 [1] |
| (3R,4S,5S,6S)-5-(Hydroxymethyl)-6-pentylpiperidine-3,4-diol | IC50 | 150000.0 [1] |
| (3R,4S,5R,6S)-5-(Hydroxymethyl)-6-pentylpiperidine-3,4-diol | IC50 | 13000.0 [1] |
| (3R,4S,5R,6R)-5-(Hydroxymethyl)-6-(2-phenylethyl)piperidine-3,4-diol | IC50 | 10.0 [1] |
| 3,4-Dichloro-N-[5-(5-chloro-benzothiazol-2-ylsulfanyl)-[1,3,4]thiadiazol-2-yl]-benzamide | IC50 | 15000.0 [1] |
| N-[6-[[5-(Dimethylamino)naphthalen-1-yl]sulfonylamino]hexyl]-6-[(2R,3S,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]hexanamide | Ki | 700.0 [1] |
| 5-Methylpiperidine-3,4-diol | IC50 | 1000000.0 [1] |
| (1S,2S,3S,6R)-6-(Decylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 43000.0 [1] |
| (1S,2S,3S,6R)-6-(3-Hydroxypropylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 1000000.0 [1] |
| (1S,2S,3S,6R)-6-(2-Methylpropylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 41000.0 [1] |
| (1S,2S,3S,6R)-6-(2-Ethylbutylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 15000.0 [1] |
| (1S,2S,3S,6R)-6-(Cyclohexylmethylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 60000.0 [1] |
| (1S,2S,3S,6R)-6-(Cyclohexylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 490000.0 [1] |
| (1S,2S,3S,6R)-6-(3-Methylbutylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 28000.0 [1] |
| (1S,2S,3S,6R)-6-(2-Phenylethylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 86000.0 [1] |
| (1S,2S,3S,6R)-6-(Butylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 50000.0 [1] |
| (1S,2S,3S,6R)-6-(Pentylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 19000.0 [1] |
| (1S,2S,3S,6R)-6-(Pentan-3-ylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 1000000.0 [1] |
| (1S,2S,3S,6R)-6-(Hexylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 56000.0 [1] |
| (1S,2S,3S,6R)-6-(Benzylamino)cyclohex-4-ene-1,2,3-triol;hydrochloride | IC50 | 180000.0 [1] |
| (1S,2S,3S,6R)-6-(Octylamino)cyclohex-4-ene-1,2,3-triol;hydrochloride | IC50 | 120000.0 [1] |
| 5-Methylene-piperidine-3,4-diol | IC50 | 1000000.0 [1] |
| 1-Butyl-5-methyl-piperidine-3,4-diol | IC50 | 1000000.0 [1] |
| 5-Methoxy-piperidine-3,4-diol | IC50 | 1000000.0 [1] |
| 1-Butyl-piperidine-3,4,5-triol | IC50 | 43000.0 [1] |
| (1S,2S,3S,6R)-4-Methyl-6-(octylamino)cyclohex-4-ene-1,2,3-triol | IC50 | 46000.0 [1] |